Oestrogen receptor beta and melanoma: A comparative study

British Journal of Dermatology

Volumn 168, Issue 3, 2013, Pages 513-519

  De Giorgi, V ^a   Gori, A ^a   Gandini, S ^b   Papi, F ^a   Grazzini, M ^a   Rossari, S ^a   Simoni, A ^a   Maio, V ^a   Massi, D ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA;

ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MELANOMA; METABOLISM; OBESITY; PHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDY; SEX DIFFERENCE; SKIN TUMOR;

ANALYSIS OF VARIANCE; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; MELANOMA; OVERWEIGHT; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; SEX FACTORS; SKIN NEOPLASMS;

EID: 84882256474     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12056     Document Type: Article

References (38)

1. Roger P, Sahla ME, Mäkelä S et al. Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumours. Cancer Res 2001;61:2537-41.
2. Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor beta in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 2003;54:79-87.
3. Drummond AE, Fuller PJ. The importance of ERβ signalling in the ovary. J Endocrinol 2010;205:15-23.
4. Bardin A, Boulle N, Lazennec G et al. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004;11:537-51.
5. Williams SC. A different side of estrogen: second receptor complicates efforts to understand hormone. Sci News 2008;173:8-9.
6. Rutherford T, Brown WD, Sapi E et al. Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol 2000;96:417-21.
7. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001;61:632-40.
8. Schwartz AG, Prysak GM, Murphy V et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7.
9. Shaaban AM, Jarvis C, Moore F et al. Prognostic significance of estrogen receptor beta in epithelial hyperplasia of usual type with known outcome. Am J Surg Pathol 2005;29:1593-9.
10. Ji Q, Liu PI, Elshimali Y, Stolz A. Frequent loss of estrogen and progesterone receptors in human prostatic tumours determined by quantitative real-time PCR. Mol Cell Endocrinol 2005;229:103-10.
11. Folkerd EJ, Dowsett M. Influence of sex hormones on cancer progression. J Clin Oncol 2010;28:4038-44.
12. De Giorgi V, Gori A, Alfaioli B et al. Influence of sex hormones on melanoma. J Clin Oncol 2011;29:e94-5.
13. De Giorgi V, Gori A, Grazzini M et al. The initiation and progression of melanoma: estrogens or estrogen receptors? Melanoma Res 2010;20:64-5.
14. Driscoll MS, Grant-Kels JM. Estrogen receptor expression in cutaneous melanoma. Arch Dermatol 2009;145:73-5.
15. Schmidt AN, Nanney LB, Boyd AS et al. Oestrogen receptor-b expression in melanocytic lesions. Exp Dermatol 2006;15:971-80.
16. De Giorgi V, Mavilia C, Massi D et al. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol 2009;145:30-6.
17. Ohata C, Tadokoro T, Itami S. Expression of estrogen receptor b in normal skin, melanocytic nevi and malignant melanoma. J Dermatol 2008;35:215-21.
18. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2005;23:4735-41.
19. Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am J Surg 1998;175:437-44.
20. Scoggins CR, Ross MI, Reintgen DS et al. Gender-related differences in outcome for melanoma patients. Ann Surg 2006;243:693-8.
21. Miller JG, Mac Neil S. Gender and cutaneous melanoma. Br J Dermatol 1997;136:657-65.
22. Joosse A, de Vries E, Eckel R et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 2011;131:719-26.
23. Thornton MJ, Taylor AH, Mulligan K et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 2003;12:181-90.
24. Thornton MJ, Taylor AH, Mulligan K et al. The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp Proc 2003;8:100-3.
25. Kwon OS, Han JH, Yoo HG et al. Expression of androgen receptor, estrogen receptor alpha and beta in the dermal papilla of human hair follicles in vivo. J Dermatol Sci 2004;36:176-9.
26. Kariya Y, Moriya T, Suzuki T et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J 2005;52:317-25.
27. Greene GL, Gilna P, Waterfield M. Sequence and expression of human estrogen receptor complementary DNA. Science 1986;231:1150-4.
28. McCarty KS Jr, Szabo E, Flowers JL et al. Use of a monoclonal antiestrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986;46(Suppl. 8):4244-8.
29. Flowers JL, Seigler HF, McCarty KS Sr et al. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody. Arch Dermatol 1987;123:764-5.
30. Cohen C, DeRose PB, Campbell WG et al. Estrogen receptor status in malignant melanoma. Am J Dermatopathol 1990;12:562-4.
31. Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392:49-53.
32. Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 2005;53:555-6.
33. Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clin Interv Aging 2007;2:283-97.
34. Sugiyama N, Barros RP, Warner M, Gustafsson JA. ERbeta: recent understanding of estrogen signaling. Trends Endocrinol Metab 2010;21:545-52.
35. Jarvinen TA, Pelto-Huikko M, Holli K, Isola J. Estrogen receptor b is coexpressed with ERa and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 2000;156:29-35.
36. Wen XF, Shen Z, Shen ZZ et al. The expression of ERβ protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer. Oncol Rep 2002;9:937-44.
37. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen signaling via estrogen receptor beta. J Biol Chem 2010;285:39575-9.
38. Speirs V, Green CA, Shaaban AM. Oestrogen receptor beta immunohistochemistry: time to get it right? J Clin Pathol 2008;61:1150-1.